Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

India Globalization Capital Inc (NY: IGC )

0.4593 +0.0172 (+3.89%)
Streaming Delayed Price Updated: 12:08 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about India Globalization Capital Inc

< Previous 1 2 3 Next >
IGC Pharma Secures $3M Via Private Placement
IGC Pharma, Inc. (AMEX:IGC) announced a strategic investment from four investment funds managed by Bradbury Asset Management (Hong Kong) Limited, an asset management firm with over $2 billion in... 
Via Benzinga
Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
Gainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company. 
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
IGC Announces Rebranding, Changes Name To IGC Pharma
India Globalization Capital, Inc. (AMEX:IGC) announced it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better... 
Via Benzinga
The Future Of The Indian Market
India has an estimated 26,000 startups, making it the third-largest startup ecosystem in the world, recording consolidated inflows of over $36 billion in the past 3 years. 
Via Talk Markets
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
India Globalization Capital, Inc. (dba IGC, Inc.) (AMEX:IGC) released its third fiscal quarter 2023 financial results, revealing revenue of $332,000, a 133% increase compared to $142,000 in the Q3... 
Via Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
India Globalization Capital, Inc. (AMEX:IGC) has received a no objection letter from Health Canada for approval of its trial, “A phase 2, multi-center, double-blind, randomized, placebo-controlled... 
Via Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
India Globalization Capital, Inc. (AMEX:IGC) has begun “A phase 2, multi-center, double-blind, randomized, placebo-controlled, trial of the safety and efficacy of IGC-AD1 on agitation in participants... 
Via Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. 
Via InvestorPlace
IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC
India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme... 
Via Benzinga
IGC Stock Slightly Up On Q1 2023 Revenue Growth Of 175%, What About Gross Profit?
India Globalization Capital, Inc. (AMEX:IGC) revenue in Q1 2023 was approximately $212,000 an increase of 175% compared to $77,000 in the same quarter of 2022. 
Via Benzinga
IGC Revenue Drops 55.8% In Fiscal 2022, What About Gross Profit?
India Globalization Capital, Inc. (AMEX:IGC) revenue in fiscal 2022 was $397,000, a 55.8% decrease compared to $898,000 in fiscal 2021. 
Via Benzinga
IGC Acquires Exclusive Rights For A Potential Alzheimer's Drug Development Candidate
One of subsidiaries of India Globalization Capital, Inc. (NYSE: IGC) reached an intellectual property license agreement for a potential Alzheimer’s drug development candidate. 
Via Benzinga
44 Stocks Moving In Friday's Mid-Day Session
Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial. 
Via Benzinga
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
69 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday. 
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382. 
Via Benzinga
IGC Receives U.S. Patent For Method And Composition For Treating Seizure Disorders, Utilizing CBD
United States Patent and Trademark Office issued a patent (#11,351,152) to the India Globalization Capital, Inc. (AMEX:IGC) titled “Method and Composition for Treating Seizure Disorders.” 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
83 Biggest Movers From Yesterday
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed... 
Via Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported... 
Via Benzinga
34 Stocks Moving in Friday's Pre-Market Session
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22... 
Via Benzinga
Cannabis Stocks That Moved On News That Federal Cannabis Legalization Bill Heads To House For Vote Next Week
The House of Representatives intends to vote on a bill to federally legalize cannabis for the second time in history next week, congressi... 
Via Benzinga
India Globalization Capital Posts Net Loss Of $2.38M For The Third Quarter
India Globalization Capital, Inc. (AMEX:IGC) announced its financial results for the three months ending December 31, 2021 – quarter three of the company’s 2022 fiscal year. Q3 Financial Highlights 
Via Benzinga
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
India Globalization Capital, Inc. (NYSE: IGC) announced Tuesday that it had received positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a... 
Via Benzinga
IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients
India Globalization Capital, Inc. (AMEX:IGC) revealed th... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.